DS0401 - Etude des systèmes biologiques, de leur dynamique, des interactions et inter-conversions au niveau moléculaire

The bridge and the shuttle : structure and dynamics of the membrane contact site formed by the sterol/PI(4)P exchanger OSBP – SwingBridge

SwingBridge

The bridge and the shuttle : structure and dynamics of the membrane contact site formed by the sterol/PI(4)P exchanger OSBP

swingbridge: objectives and main issues

The overall goal of the project is to obtain the first 3D functional structural and dynamical model of OSBP in MCS. We want to highlight two particularly innovative aspects of this project. The first is the use of cryo-EM to determine the MCSs structure. Cryo-EM will provide 3D models of both proteins and membrane otherwise difficulty to build from classical approaches of structural biology. The second innovative aspect is the design and the use of new and dedicated in vitro systems to analyze the dynamic of assembly/disassembly based on giant unilamellar vesicle (GUV). We want to answer to the following 3 questions: 1. What are the key elements for the functional and structural architecture of OSBP-MCS ? Using chosen constructs, the role of each protein element will be assigned by combining approaches of cell biology, in vitro functional studies with membrane models and cryo-EM. 2. What is the structure of OSBP-MCS? Several atomic models of parts of OSBP or other ORP/Osh proteins, as well as of the cytoplasmic domain of VAP-A are known. However, the structure of full-length OSBP and even more, OSBP in interaction with full-length VAP-A F between two facing membrane is lacking. Thus the functional architecture of OSBP in MCS is unknown and only putative models are used to conduct in cellulo and in vitro experiments. We have obtained a first visualization of a MCS by cryo-electron tomography (cryo-ET) that validated the feasibility of the cryo-EM reconstruction. 3. What is the dynamics of assembly and disassembly of MCS? A specificity of OSBP-MCS and likely of other ORPs is that the existence of MCS is directly coupled to the transport of lipids. This coupling involves the diffusion and assembly, including that of VAP-A F in the membrane, of the constitutive proteins and transported lipids as of the internal dynamics of the ORD domains. We will combine reconstitution of MCS in micron sized GUV and use fluorescence microscopy and FRAP measurements.

we will explore OSBP-mediated MCS by two approaches: 1. Cryo-EM to get structural information (Partner 1). The goal is to determine the first 3D model of MCS. 2. Real time measurements to get information on dynamics of assembly/disassembly of MCS and of lipid transfer (Partner 2). In both cases, we will design new in vitro membrane systems. We rely on our complementary expertise in cell biology, membrane biochemistry and structural biology as well as on solid preliminary data.

experiments in progress

Contacts between cellular compartments membranes and especially between the ER where lipid are synthetized and other organelles are identified and their major role in lipid homeostasis is accepted. Disorders of this great cell function are increasingly cited in serious human diseases and some involved proteins are already identified as target of pharmacophores. The clinical translation is not yet accomplished and the field continuously feeds of fundamental advances. There is a network of results concerning various proteins involved in the MCS and structural and functional homologies are being understood. This project addresses two issues that hinder the understanding of the dual function of MCSs between ER and trans-Golgi. First visualizing, at the molecular level, these MCSs must fill the incomplete 3D models built on atomic data of sub-domains and establish the structure-function relationships necessary to understand the roles of each protein component in the tethering and in the transport of lipids. Second, this 3D model only makes sense if it is correlated with the dynamics, at the molecular level, of assembly and disassembly of MCSs which is a key element of their function during cell life. These two issues are common to other MCSs and given the strong homology between lipid transfer proteins, it is very likely that our results will be universal.

in preparation

Cellular compartmentalization is a hallmark of eukaryotic cells. It allows specialized functions to be confined in a specific environment. However, it also implies exchange of material between compartments. Intracellular trafficking mediated by vesicles contributes to these exchanges and the associated mechanisms have been heavily explored (Nobel Prize in Physiology and Medicine 2013). Another important mechanism supported by recent studies involves the formation of membrane junctions by which organelles communicate without membrane fusion. These narrow (<30 nm) cytosolic gaps, refereed as to membrane contact sites (MCS), are of key importance for intracellular lipid transport. They also play significant roles in intracellular signaling, organelle inheritance, and lipid metabolism and have received considerable attention in recent years due to their implication in some metabolic diseases.
MCS are conserved in all eukaryotic cells and generally join the endoplasmic reticulum (ER) with other organelles. As a result, a newly biosynthesized lipid molecule in the ER can rapidly reach another organelle by trafficking through a MCS. Lipid transfer proteins present in MCS have recently been identified as the intracellular targets of several anticancer and antiviral compounds, emphasizing their important role in cellular homeostasis. Not surprisingly, some intracellular bacterial pathogens hijack these proteins to exploit their lipid transport activities.
Cell biology and electron microscopy studies have delineated the key characteristics of MCS: 1. MCS are associated with specific functions including lipid transfer, calcium or apoptosis signaling. 2. MCS consist in assemblies of integral or membrane bound proteins present on each side of membranes and joined by cytoplasmic domains. 3. MCS are highly dynamic and regulated.
Current challenges in MCS research are thus clearly identified. At the structural level, the structure of some individual soluble proteins or domains has been solved but a structural description of complete architecture of MCS is lacking. Cryo-electron microscopy (cryo-EM), the expertise of the Partner 1 (Institut Curie, Paris), is the most suitable structural approach to visualize the full protein complex between two facing membranes. Moreover, MCS are now accessible to high resolution cryo-EM thanks to the current resolution in resolution. At the functional level, the dynamics and regulation of these junctions remain to be explored. Resolving these two issues requires the design of new cellular and in vitro assays adapted to the confined environment of MCS.
The Partner 2 (IPMC, Valbonne) has recently reconstituted the first functional MCS (Mesmin, Cell 2013). This MCS bridges the endoplasmic reticulum to the trans side of the Golgi apparatus and consists of a complex between oxysterol binding protein (OSBP), the ER protein VAP-A and the Golgi protein Arf1-GTP.
Based on this finding, we will explore OSBP-mediated MCS by two approaches: 1. Cryo-EM to get structural information (Partner 1). The goal is to determine the first 3D model of MCS. 2. Real time measurements to get information on dynamics of assembly/disassembly of MCS and of lipid transfer (Partner 2). In both cases, we will design new in vitro membrane systems. We rely on our complementary expertise in cell biology, membrane biochemistry and structural biology as well as on solid preliminary data. Deciphering the functional and structural principles underlying the action of OSBP will have a global impact, given specific domains among lipid transfer proteins are conserved. The tools and concepts developed here will also enrich the current vision of the dynamics of intracellular compartments and should trigger significant findings in pharmacological therapies of associated diseases. Thus, this proposal is in line with the goals of “Défi 4, Axe 1” for decrypting the spatial and temporal multi-scales mechanisms of the cell.

Project coordination

Daniel LEVY (INSTITUT CURIE - SECT DE RECHERCHE)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

IPMC Institut de Pharmacologie Moléculaire et Cellulaire
INSTITUT CURIE - SECT DE RECHERCHE

Help of the ANR 426,709 euros
Beginning and duration of the scientific project: December 2015 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter